{"id":7087,"date":"2021-10-27T11:40:57","date_gmt":"2021-10-27T11:40:57","guid":{"rendered":"https:\/\/europeanvenousforum.org\/?page_id=7087"},"modified":"2021-10-27T11:40:57","modified_gmt":"2021-10-27T11:40:57","slug":"21st-evf-scientific-programme","status":"publish","type":"page","link":"https:\/\/europeanvenousforum.org\/index.php\/21st-evf-scientific-programme\/","title":{"rendered":"21st EVF Scientific Programme"},"content":{"rendered":"

21st<\/sup> Virtual<\/em> Meeting of the European Venous Forum<\/h2>\n

24-26 June 2021<\/p>\n

PROVISIONAL SCIENTIFIC PROGRAMME<\/p>\n

Online Programme<\/a>  |  <\/em>Scientific Programme<\/em><\/a>  | Scientific Programme & Book of Abstracts<\/a><\/em><\/p>\n

All hours on timeline in BST <\/strong><\/em><\/p>\n

 <\/p>\n

\"\"18 European CME Credits (ECMECs)<\/strong><\/em><\/p>\n

The conference has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME\u00ae) for a maximum of 18 European CME credits (ECMEC\u00aes). CME credits are awarded for attendance of the live presentations during the 3 days of the conference and for attendance of the recorded presentations viewed within three months of the event.<\/em><\/p>\n

Individual delegates access to meeting rooms will be monitored to provide a certificate of attendance with a number of CME credits (1 CME credit per 1 hour of attendance).<\/em><\/p>\n

 <\/p>\n

Recordings will be available to all registered delegates for one year post conference<\/p>\n

 <\/p>\n

<\/a><\/p>\n

THURSDAY 24 JUNE 2021<\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08.30-10.30<\/td>\n\n
    \n
  • Abstract Session 1:<\/strong> (10 minute presentation, 10 minute discussion)<\/li>\n
  • Venous Thromboembolism, Anticoagulation, Iliac Stenting, Villalta Scale<\/strong><\/li>\n
  • Chair: I Bihari (Hungary), A Nicolaides (Cyprus)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
08.30       1.1<\/td>\n\n
    \n
  • Comparison of thrombus regression between direct oral anticoagulants and warfarin in patients with deep vein thrombosis.<\/strong><\/li>\n
  • Hosoi Yutaka; Nunokawa Masao; Mochizuki Yasuaki; Ichikawa Yohei; Sasajima Hiroshi; Fujimaki Keisuke; Kubota, Hiroshi<\/em><\/li>\n
  • Cardiovascular Surgery, Kyorin University, Tokyo, Japan<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
08.50       1.2<\/td>\n\n
    \n
  • Gender-related hemorrhagic events during rivaroxaban therapy.<\/strong><\/li>\n
  • Dzhenina Olga; Bogachev Vadim<\/em><\/li>\n
  • First Phlebological Centre, Moscow, Russia<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.10      1.3<\/td>\n\n
    \n
  • Sulodexide may accelerate and promote deep vein thrombosis resolution<\/strong><\/li>\n
  • Aldrett Lee, Erasto<\/u>1<\/sup>; Fratti Munari, Alberto2<\/sup><\/em><\/li>\n
  • 1<\/sup>Grupo de Atenci\u00f3n Vascular Integral, San Luis Potosi, Mexico; 2<\/sup>Grupo de Atencion Vascular Integral, Mexico City, Mexico;<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.30       1.4<\/td>\n\n
    \n
  • Risk factors and frequency of recurrent long-term venous thromboembolism after superficial vein thrombosis of the lower limbs.<\/strong><\/li>\n
  • Papageorgopoulou Chrysanthi P; Kakkos Stavros; Nikolakopoulos Konstantinos M; Ntouvas Ioannis; Papadoulas Spyros; Kouri Anastasia; Tsantrizos Polyzois<\/em><\/li>\n
  • Vascular Surgery, University Hospital of Patras, Patras, Greece<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.50       1.5<\/td>\n\n
    \n
  • Quality of life outcomes after iliac vein stenting for chronic deep venous obstruction: a tertiary centre experience using the VEINES-QoL\/SYM.<\/strong><\/li>\n
  • Morris Rachael; Pouncey Anna; Khan Taha; Gwozdz, Adam; Quintana, Belen; Saha Prakash; Black Stephen<\/em><\/li>\n
  • Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Sciences, St Thomas\u2019 Hospital, London, UK<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

10.10       1.6<\/td>\n\n
    \n
  • Assessment of the Villalta tool in a population with primary chronic venous disease.<\/strong><\/li>\n
  • Kemal Kemal; Onida Sarah; Davies Alun<\/em><\/li>\n
  • Imperial College London, London, UK<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

10.30-11.00<\/td>\nView ePoster Presentations<\/a> and visit Virtual Exhibition<\/td>\n<\/tr>\n
11.00-13.00<\/td>\n\n
    \n
  • Abstract Session 2:<\/strong> (10 minute presentation, 10 minute discussion)<\/li>\n
  • Thermal ablation, Cyanoacrylate, Sclerotherapy, Haemodynamics<\/strong><\/li>\n
  • Chair: D Heim (Switzerland), A Szabo (Hungary)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
11.00      2.1<\/td>\n\n
    \n
  • Randomised clinical trial of mechanochemical ablation versus cyanoacrylate adhesive for the treatment of varicose veins (MOCCA).<\/strong><\/li>\n
  • Belramman Amjad1<\/sup>; Lane Tristan R A1<\/sup>; Bootun Roshan1<\/sup>; Tang Tjun Yip2<\/sup>; Davies Alun H1<\/sup><\/em><\/li>\n
  • 1<\/sup>Imperial College London, London, London, UK; 2<\/sup>Singapore General Hospital and Sengkang General Hospital, Singapore., Singapore, Singapore<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

11.20       2.2<\/td>\n\n
    \n
  • Mid-term results of cyanoacrylate embolization for saphenous veins: efficacy, complications and their treatment<\/strong>.<\/li>\n
  • Murzina Elena1<\/sup>; Lobastov Kirill2<\/sup>; Bargandzhiya Astanda2<\/sup>; Laberko Leonid2<\/sup>; Popov Ivan3<\/sup><\/em><\/li>\n
  • 1<\/sup>Hospital \u00abNeftyanik\u00bb, Tyumen, Russia; 2<\/sup>Pirogov Russian National Research Medical University, Moscow, Russia; 3<\/sup>Tyumen State Medical University, Tyumen, Russia<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
11.40       2.3<\/td>\n\n
    \n
  • Mechanisms of damage to the venous wall and dissolving venaseal glue in an animal experiment.<\/strong><\/li>\n
  • Markin SM.1<\/sup>; Mazayshvili KV.2<\/sup>; Agalarov RM.2<\/sup>; Gustelev YuA.2<\/sup>; Gitsuk YaV.1<\/sup>; Mordovin, A.I.1<\/sup><\/em><\/li>\n
  • 1<\/sup>Federal State Budgetary Health Institution \u201cSt. Petersburg Clinical Hospital of the Russian Academy of Sciences, Saint-Petersburg, Russia; 2<\/sup>Department of Faculty Surgery, Surgical University, Surgut State University, Surgut, Russia<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

12.00       2.4<\/td>\n\n
    \n
  • Efficacy and safety of radiofrequency thermal ablation of great saphenous vein compared to saphenous-femoral junction ligature and stripping. A randomized exploratory study.<\/strong><\/li>\n
  • Reina-Gutierrez Lourdes1<\/sup>; Fern\u00e1ndez-Solares Jose Ignacio1<\/sup>; Nowak-Tarnawska, Agnieszka1<\/sup>; Barrio-Rodriguez, Carlos1<\/sup>;Florez-Gonzalez, Aurora1<\/sup>;Laime-Alvarez, Ilsem1<\/sup>; Fern\u00e1ndez-P\u00e9rez, Cristina2<\/sup>; Sanjuanbenito-Reina, Alfonso3<\/sup><\/em><\/li>\n
  • 1<\/sup>Vascular Department, Hospital Central de la Cruz Roja, Madrid, Spain; 2<\/sup>Epidemiology Unit, Hospital Clinico San Carlos, Madrid, Spain; 3<\/sup>Grade of Medicine, Autonoma University, Madrid, Spain<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
12.20       2.5 <\/p>\n

 <\/p>\n

 <\/td>\n

\n
    \n
  • The study of systemic hemodynamic disorders in patients with varicose veins and post-thrombotic syndrome.<\/strong><\/li>\n
  • Suchkov Igor; Kalinin Roman; Mzhavanadze Nina; Shanaev Ivan<\/em><\/li>\n
  • Ryazan State Medical University, Ryazan, Russia<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

12.40       2.6<\/td>\n\n
    \n
  • Ultrasound-guided foam sclerotherapy on larges great saphenous veins (over 8 mm diameter) with 1% vs 2% vs 3% polidocanol: A randomised trial.<\/strong><\/li>\n
  • Amorim Cl\u00e1udia; Virgini-Magalh\u00e3es Carlos Eduardo; Bandeira Julia<\/em><\/li>\n
  • Vascular and Endovascular Surgery, University Hospital Pedro Ernesto, Rio de Janeiro, Brazil<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

13.00-14.00<\/td>\nView ePoster Presentations<\/a> (4 minute presentations) \u2013 See separate page for programme<\/em><\/td>\n<\/tr>\n
13.00-14.00<\/td>\nVisit Virtual Exhibition<\/td>\n<\/tr>\n
14.00-15.00<\/td>\nIndustry Session 1<\/strong><\/a><\/td>\n<\/tr>\n
15.00-16.00<\/td>\n\n
    \n
  • Didactic Session 1<\/strong> (10 minute presentation, 5 minute discussion)<\/li>\n
  • Messages from New Guidelines, Laser Crossectomy<\/strong><\/li>\n
  • Chair: Marianne De Maeseneer (Belgium), F Zernovicky (Slovakia)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
15.00<\/td>\nHighlights of Guidelines of DVT management.<\/strong> Stavros Kakkos (Greece)<\/em><\/td>\n<\/tr>\n
15.15<\/td>\nLaser ablation, radiofrequency ablation, surgery and ultrasound guided foam sclerotherapy: what do the new guidelines say and how do we apply it in practice?<\/strong> A Giannoukas (Greece)<\/em><\/td>\n<\/tr>\n
15.30<\/td>\nCompression: Messages from the International Guidelines.<\/strong> G Szolnoky (Hungary)<\/em><\/td>\n<\/tr>\n
15.45<\/td>\nLaser crossectomy. Twelve years and 2,300 cases.<\/strong> I Bihari (Hungary)<\/em><\/td>\n<\/tr>\n
16.00-16.30<\/td>\nView ePoster Presentations<\/a>  |  Visit Virtual Exhibition<\/td>\n<\/tr>\n
16.30-18.10<\/td>\n\n
    \n
  • Didactic Session 2<\/strong> (10 minute presentation, 10 minute discussion)<\/li>\n
  • Advanced CVD, MOCA, Cyanoacrylate, New devices<\/strong><\/li>\n
  • Chair: Alun Davies (UK), G Szolnoky (Hungary)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
16.30<\/td>\nEndovenous procedures in patients with venous ulcers.<\/strong> G Menyhei (Hungary)<\/em><\/td>\n<\/tr>\n
16.50<\/td>\nCost-benefit of venous stenting.<\/strong> C Rognoni (Italy)<\/em><\/td>\n<\/tr>\n
17.10<\/td>\nVenous insufficiency, barrier function of the microbiome and ulcer development.<\/strong> J Dar\u00f3czy (Hungary)<\/em><\/td>\n<\/tr>\n
17.30<\/td>\nMOCA: is it here to stay?<\/strong> A Szab\u00f3 (Hungary)<\/em><\/td>\n<\/tr>\n
17.50<\/td>\nCyanoacrylate: Efficacy and Risks.<\/strong> T Proebstle (Germany)<\/em><\/td>\n<\/tr>\n
18.10<\/td>\nOutlook into the future of VV therapy and the promise of new devices for telangiectasia.<\/strong> Dominik Heim (Switzerland)<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/strong><\/p>\n

<\/a><\/p>\n

FRIDAY 25 JUNE 2021<\/h3>\n

 <\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
08.30-10.30<\/td>\n\n
    \n
  • Abstract Session 3:<\/strong> (10 minute presentation, 10 minute discussion)<\/li>\n
  • Miscellaneous<\/strong><\/li>\n
  • Chair: Mark Malouf (Australia), Armando Mansilha (Portugal)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
08.30       3.1<\/td>\n\n
    \n
  • The evolution of venous symptoms after interventional treatment for varicose veins.<\/strong><\/li>\n
  • Lobastov Kirill; Bargandzhiya Astanda; Laberko Leonid; Dvornikov Anton<\/em><\/li>\n
  • Pirogov Russian National Research Medical University, Moscow, Russia<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
08.50       3.2<\/td>\n\n
    \n
  • V-move 2 v-care project: veines-QOL questionnaire was a valuable tool in assessing quality of life for patients presenting with venous ulcer in India over a 2 year period<\/strong>.<\/li>\n
  • Jindal Ravul1<\/sup>; Gupta P2<\/sup>; Dekiwadia Devendra3<\/sup><\/em><\/li>\n
  • 1<\/sup>Fortis Hospital, Mohali, India; 2<\/sup>Private, Mumbai, India; 3<\/sup>Dekiwadia Hospital, Rajkot, India<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.10       3.3<\/td>\n\n
    \n
  • Evaluation of microvalve alteration and assessment of MPFF treatment in an experimental model of venous hypertension.<\/strong><\/li>\n
  • Bouskela, Eliete1<\/sup>; Garcia de Almeida Cyrino, Fatima Zely1<\/sup>; Blanc-Guillemaud, Vanessa2<\/sup><\/em><\/li>\n
  • Cardiovascular and Metabolic Diseases Center for Therapeutic Innovation; Lucien, Arnaud2<\/sup>; Cardiovascular and Metabolic Diseases Center for Therapeutic Inn1 <\/sup>Laboratory for Clinical and Experimental Research on Vascular Biology, Biomedical Center, State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2<\/sup>Institut de Recherches Internationales Servier (I.R.I.S.), Suresnes Cedex, France<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.30       3.4<\/td>\n\n
    \n
  • The impact of lower body compression garment on left ventricular rotational mechanics in patients with secondary leg lymphedema and lipedema.<\/strong><\/li>\n
  • Szolnoky, Gyozo1<\/sup>; Korm\u00e1nyos, \u00c1rp\u00e1d2<\/sup>; Domsik, P\u00e9ter2<\/sup>; Kalapos, Anita2<\/sup>; Kem\u00e9ny, Lajos1<\/sup>; Forster, Tam\u00e1s2<\/sup>; Nemes, Attila2<\/sup>;<\/em><\/li>\n
  • 1<\/sup>Department of Dermatology and Allergology; 2<\/sup>2nd Department of Medicine and Cardiology Centre, University of Szeged, Szeged, Hungary<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
09.50       3.5<\/td>\n\n
    \n
  • Factors, which are secreted by the venous endothelium upon exposure to oscillatory shear stress, affect adjacent cell layers of the vein wall.<\/strong><\/li>\n
  • Smetanina Mariia1; Shirshova Arina2; Zolotukhin Igor3; Shevela Andrey1 Filipenko Maxim1;<\/em><\/li>\n
  • 1Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine (ICBFM); Novosibirsk State University (NSU), Novosibirsk, Russia; 2Institute of Chemical Biology and Fundamental Medicine (ICBFM), Novosibirsk, Russia; 3Faculty of Surgery, Medical Department, Pirogov Russian National Research Medical University (RNRMU); Institute of Chemical Biology and Fundamental Medicine (ICBFM), Moscow, Russia<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

10.10       3.6<\/td>\n\n
    \n
  • Could it be effective? Non-inferiority randomised trial of new type of compression stockings.<\/strong><\/li>\n
  • Demekhova, Marina1<\/sup>; Zolotukhin, Igor2<\/sup>; Ilyukhin, Evgeny1<\/sup>; Sonkin, Igor3<\/sup>; Zakharova, Elena2<\/sup>; Kiseleva, Ekaterina3<\/sup>; Efremova, Oksana2<\/sup>; Gavrilov, Evgenii4<\/sup><\/em><\/li>\n
  • 1<\/sup>Medalp clinic, Saint Petersburg, Russia; 2<\/sup>Pirogov Russian National Research Medical University, Moscow, Russia; 3<\/sup>Road Clinical Hospital of Russian Railways, Saint Petersburg, Russia; 4<\/sup>Military Medical Academy, Saint Petersburg, Russia<\/li>\n<\/ul>\n

    Submitted for the EVF Prize<\/strong><\/em><\/td>\n<\/tr>\n

10.30-11.00<\/td>\nView ePoster Presentations<\/a> and visit Virtual Exhibition<\/td>\n<\/tr>\n
11.00-12.00<\/td>\nIndustry Session 2<\/strong><\/a><\/td>\n<\/tr>\n
12.00-13.00<\/td>\n\n
    \n
  • EVF Invited Lecture<\/strong><\/li>\n
  • Chair: I Bihari (Hungary)<\/em><\/li>\n
  • Introduction by Imre Bihari<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
12.00-13.00<\/td>\nThe Best Vein Care is the Only Vein Care to be Considered.<\/strong> P Gloviczki (USA)<\/em><\/td>\n<\/tr>\n
12.30-13.00<\/td>\n\n
    \n
  • Didactic Session 3<\/strong> (10 minute presentation, 5 minute discussion)<\/li>\n
  • New Messages on VTE<\/strong><\/li>\n
  • Chair: Stavros Kakkos (Greece), Athanasios Giannoukas (Greece)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
12.30-12.45<\/td>\nEfficacy of adjunctive IPC to standard prophylaxis of post-operative VTE in patients at extremely high risk.<\/strong> Kirill Lobastov (Russia)<\/em><\/td>\n<\/tr>\n
12.45-13.00<\/td>\nCOVID-19 and VTE.<\/strong> A Nicolaides (Cyprus)<\/em><\/td>\n<\/tr>\n
13.00-14.00<\/td>\nView ePoster Presentations<\/a> (4 minute presentations) \u2013 See separate page for programme<\/em><\/td>\n<\/tr>\n
13.00-14.00<\/td>\nVisit Virtual Exhibition<\/td>\n<\/tr>\n
14.00-15.00<\/td>\nEVF Annual General Meeting (Members Only)<\/strong><\/td>\n<\/tr>\n
15.00-16.00<\/td>\n\n
    \n
  • Joint EVF\/AVF Session <\/strong>(10 minute presentations, 5 minute discussion)<\/li>\n
  • Current Controversies<\/strong><\/li>\n
  • Chair: Peter Gloviczky (USA), Z Pecsvarady (Hungary)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
15.00<\/td>\nIliac vein stenting for patients with the PTS.<\/strong> S Black (UK)<\/em><\/td>\n<\/tr>\n
15.15<\/td>\nThrombolysis in the prevention of PTS.<\/strong> N Baekgaard (Denmark)<\/em><\/td>\n<\/tr>\n
15.30<\/td>\nHow can infra-inguinal duplex be optimized to detect proximal iliac vein obstruction?<\/strong> Elna Masuda (USA)<\/em><\/td>\n<\/tr>\n
15.45<\/td>\nPhysician, Heal Thyself.<\/strong> Brajesh Lal (USA)<\/em><\/td>\n<\/tr>\n
16.00-16.30<\/td>\nVisit ePoster Presentations<\/a>  |  Visit Virtual Exhibition<\/td>\n<\/tr>\n
16.30-17.30<\/strong><\/td>\nIndustry Session 3<\/strong><\/a><\/td>\n<\/tr>\n
17.30-18.00<\/strong><\/td>\n\n
    \n
  • Prize winning papers from the Japanese Society of Phlebology and American Venous Forum<\/strong><\/li>\n
  • (10 minute presentation, 5 minute discussion)<\/li>\n
  • Chair: Bo Eklof (Sweden), Brajesh Lal (USA)<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
17.30-17.45  | Pr.1<\/td>\n\n
    \n
  • Definite diagnosis of lymphedema using lymphatic echography.<\/strong><\/li>\n
  • Hisako Hara<\/u>, Makoto Mihara<\/em><\/li>\n
  • Department of Lymphatic and Reconstructive Surgery, JR Tokyo General Hospital, Tokyo, Japan<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
17.45-18.00  | Pr.2<\/td>\n\n
    \n
  • Investigating a role for platelets in venous in-stent stenosis in patients with post-thrombotic syndrome<\/strong><\/li>\n
  • 1 <\/sup>Gwozdz AM, 1<\/sup>Black SA, 1<\/sup>Morris R, 1<\/sup>Messiha S, 1<\/sup>Ikram M, 2<\/sup>Bye AP, 2<\/sup>Gibbins JM, 3<\/sup>Rand ML, 1<\/sup>Patel AS, 1<\/sup>Modarai BM, 1<\/sup>Smith A, 1<\/sup>Saha P.<\/em><\/li>\n
  • 1<\/sup>Academic Department of Vascular Surgery, Section of Vascular Risk and Surgery, School of Cardiovascular Medicine and Science, St Thomas\u2019 Hospital, King\u2019s College London, UK, 2<\/sup>Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, UK, 3<\/sup>Division of Hematology\/Oncology, The Hospital for Sick Children, Toronto, Canada<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
18.00<\/td>\n\n